Medicinska fakulteten

Organisation: fakultet

Fler filtreringsmöjligheter
  1. Von Willebrand disease.

    Erik Berntorp, 2012, I: Pediatric Blood & Cancer.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  2. Von Willebrand disease - aspects of diagnosis, prophylaxis and outcome

    Elena Holm, 2018, Lund: Lund University: Faculty of Medicine. 51 s.

    Forskningsoutput: AvhandlingDoktorsavhandling (sammanläggning)

  3. Von Willebrand disease prophylaxis network

    T. Abshire, J. Bowen & Erik Berntorp, 2010, I: Haemophilia. 16, s. 147-147

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  4. Von Willebrand disease - the 'Dos' and 'Don'ts' in surgery

    Wolfgang Miesbach & Erik Berntorp, 2017, I: European Journal of Haematology. 98, 2, s. 121-127

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. von Willebrand disease update: diagnostic and treatment dilemmas

    P H B Bolton-Maggs, D Lillicrap, J Goudemand & Erik Berntorp, 2008, I: Haemophilia. 14, s3, s. 56-61

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. Von Willebrand factor/factor VIII concentrate (Haemate(R) P) dosing based on pharmacokinetics: a prospective multicenter trial in elective surgery.

    Stefan Lethagen, P A Kyrle, G Castaman, S Haertel & P M Mannucci, 2007, I: Journal of Thrombosis and Haemostasis. 5, Apr 16, s. 1420-1430

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. von Willebrand factor mediates increased platelet retention in recurrent thrombotic thrombocytopenic purpura

    D Karpman, S Lethagen, Anne Kristoffersson, C. Isaksson & Lars Holmberg, 1997 dec, I: Thrombosis and Haemostasis. 78, 6, s. 1456-62 7 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma)

    Agneta Scheja, Anita Åkesson, Pierre Geborek, Marie Wildt, Claes B Wollheim, Frank Wollheim & Ulrich M Vischer, 2001, I: Arthritis Research & Therapy. 3, 3, s. 178-182

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. von Willebrand's disease: a report from a meeting in the Åland islands.

    Erik Berntorp, I Peake, U Budde, M Laffan, R Montgomery, J Windyga, A Goodeve, A B Petrini, M von Depka, W Miesbach, D Lillicrap, A B Federici, R Lassila & G White, 2012, I: Haemophilia. 18 Suppl 6, s. 1-13

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. Von Willebrand's disease caused by compound heterozygosity for a substitution mutation (T1156M) in the D3 domain of the von Willebrand factor and a stop mutation (Q2470X).

    Stefan Lethagen, Christina Isaksson, Charlotta Schaedel & Lars Holmberg, 2002, I: Thrombosis and Haemostasis. 88, 3, s. 421-426

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift